Location History:
- Chang Hua, TW (2003 - 2008)
- Taipei, TW (2016)
- Kaohsiung, TW (2013 - 2022)
Company Filing History:
11 out of 144 
4 out of 685 
1 out of 133 
Years Active: 2003-2022
Title: Innovations by Tian-Lu Cheng in Cancer Therapy
Introduction
Tian-Lu Cheng, based in Kaohsiung, Taiwan, is an accomplished inventor with a remarkable portfolio of 15 patents. His innovative work primarily focuses on bi-specific antibodies and compounds that target cancer treatment and associated side effects, demonstrating his commitment to advancing medical science.
Latest Patents
Among his latest patents, Cheng has developed a bi-specific antibody designed to specifically target cancer cells by binding to tumor antigens. This innovative therapeutic strategy enables the suppression of cancer growth and helps block the invasion and metastasis of cancerous cells. The bi-specific antibody includes a unique first antigen binding site that attaches to polyethylene glycol (PEG) and a second site that targets ligands such as tumor antigens.
Another notable invention is the pyrazolo[4,3-c]quinoline derivatives, which exhibit targeted inhibition of microbiota β-glucuronidase. This development promises significant benefits in preventing chemotherapy-induced diarrhea (CID) in cancer patients, enhancing both the efficacy of chemotherapy and providing a health-food supplement to mitigate carcinogen-induced colon carcinoma.
Career Highlights
Cheng's career is marked by his affiliation with prestigious research institutions such as Kaohsiung Medical University and Academia Sinica. His work at these institutions has been instrumental in pioneering research that merges biotechnology and pharmacology to create effective therapeutic solutions for challenging medical conditions.
Collaborations
Throughout his career, Cheng has collaborated with esteemed colleagues, including Steve R. Roffler and Kuo-Hsiang Chuang. These collaborations have fostered a creative environment leading to groundbreaking inventions and advancements in cancer treatment methodologies.
Conclusion
Tian-Lu Cheng's contributions to the field of medical innovation are noteworthy, particularly in the realm of cancer therapy. His advancements in bi-specific antibodies and pyrazolo[4,3-c]quinoline derivatives illustrate his dedication to improving patient outcomes and effectively addressing the complexities of cancer treatment. As he continues to innovate, Cheng's work is likely to make a lasting impact on the medical community and patients worldwide.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.